Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 48 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 40 | 1,579−8.6%/yr | −8.6%/yr | 3.31.1× | 9% | 1,920 in 2030+3.3%/yr |
| Lumbar fusion | 38 | 1,451−4.5%/yr | −4.5%/yr | 3.11.1× | 2% | 1,850 in 2030+4.1%/yr |
| Cervical fusion & disc arthroplasty | 9 | 723−4.6%/yr | −4.6%/yr | 1.51.1× | 0% | 840 in 2030+2.4%/yr |
| Kyphoplasty & vertebroplasty | 1 | 310−5.8%/yr | −5.8%/yr | 0.70.5× | 8% | 290 in 2030−1.1%/yr |
| SI joint fusion | 3 | 178+21%/yr | +21%/yr | 0.31.8× | 41% | 350 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 163 | 25,835−3.4%/yr | −3.4%/yr | 53.90.7× | 35% | 32,300 in 2030+3.8%/yr |
| Skin substitutes & wound grafts | 15 | 3,990+14%/yr | +14%/yr | 4.80.6× | 50% | 5,210 in 2030+4.5%/yr |
| Bone graft & orthobiologics | 6 | 371−9%/yr | −9%/yr | 0.81.2× | 0% | 410 in 2030+1.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 88 | 4,824+0.9%/yr | +0.9%/yr | 10.11.2× | 73% | 6,880 in 2030+6.1%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 10 | 570+1.3%/yr | +1.3%/yr | 1.11.0× | 65% | 1,150 in 2030+12%/yr |
| Spinal cord & DRG stimulation | 12 | 445−2.2%/yr | −2.2%/yr | 0.91.3× | 87% | 660 in 2030+6.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 9 | 1,536−8.4%/yr | −8.4%/yr | 3.20.8× | 0% | 2,960 in 2030+12%/yr |
| Dialysis access | 31 | 1,328−18%/yr | −18%/yr | 3.10.6× | 42% | 1,660 in 2030+3.8%/yr |
| Superficial venous ablation | 14 | 975−3.2%/yr | −3.2%/yr | 2.00.6× | 88% | 1,710 in 2030+9.8%/yr |
| Thrombectomy, IVC filters & venous stents | 3 | 534−2.8%/yr | −2.8%/yr | 1.20.8× | 0% | 1,150 in 2030+14%/yr |
| Carotid revascularization | 6 | 404−8.6%/yr | −8.6%/yr | 0.90.7× | 0% | 530 in 2030+4.6%/yr |
| Aortic endografts (EVAR/TEVAR) | 0 | 187−8.9%/yr | −8.9%/yr | 0.40.9× | 0% | 190 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 18 | 2,581−3.2%/yr | −3.2%/yr | 6.11.0× | 8% | 3,830 in 2030+6.8%/yr |
| Cholecystectomy & appendectomy | 23 | 1,976−5.3%/yr | −5.3%/yr | 4.51.0× | 2% | 2,420 in 2030+3.5%/yr |
| Colorectal resection | 1 | 849−4.5%/yr | −4.5%/yr | 1.91.1× | 0% | 1,120 in 2030+4.8%/yr |
| Antireflux & hiatal hernia surgery | 3 | 341−4.9%/yr | −4.9%/yr | 0.81.0× | 0% | 500 in 2030+6.7%/yr |
| Breast reconstruction | 1 | 226−8.1%/yr | −8.1%/yr | 0.51.2× | 16% | 310 in 2030+5.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 47 | 1,837−5.2%/yr | −5.2%/yr | 4.10.7× | 5% | 2,500 in 2030+5.3%/yr |
| BPH procedures | 25 | 1,559−8.7%/yr | −8.7%/yr | 3.40.7× | 14% | 1,980 in 2030+4.1%/yr |
| Hysterectomy, hysteroscopy & ablation | 18 | 1,547−1%/yr | −1%/yr | 3.81.3× | 9% | 2,280 in 2030+6.7%/yr |
| Incontinence, prolapse & sacral neuromodulation | 16 | 1,110+0.9%/yr | +0.9%/yr | 2.41.1× | 7% | 1,930 in 2030+9.7%/yr |
| Prostatectomy & nephrectomy | 10 | 773+1.1%/yr | +1.1%/yr | 1.91.4× | 0% | 1,410 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 14 | 1,403−0.1%/yr | −0.1%/yr | 3.10.9× | 92% | 2,620 in 2030+11%/yr |
| Cochlear implants | 4 | 131+1.6%/yr | +1.6%/yr | 0.31.6× | 0% | 180 in 2030+5.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 64 | 3,656−3.2%/yr | −3.2%/yr | 8.71.2× | 38% | 4,430 in 2030+3.2%/yr |
| Tumor ablation | 7 | 358+1.3%/yr | +1.3%/yr | 0.82.8× | 0% | 500 in 2030+5.8%/yr |
| Tumor & fibroid embolization | 4 | 239+0.6%/yr | +0.6%/yr | 0.51.0× | 45% | 380 in 2030+7.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 116 | 12,114+19%/yr | +19%/yr | 26.20.9× | 80% | 25,600 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 54 | 2,678−1.9%/yr | −1.9%/yr | 6.21.2× | 2% | 3,620 in 2030+5.2%/yr |
| EP ablation | 48 | 1,991+7%/yr | +7%/yr | 3.61.1× | 0% | 4,870 in 2030+16%/yr |
| LAA occlusion & loop recorders | 42 | 1,476+9.6%/yr | +9.6%/yr | 2.80.9× | 3% | 3,650 in 2030+16%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 82 | 3,062−7.9%/yr | −7.9%/yr | 5.30.9× | 0% | 3,640 in 2030+2.9%/yr |
| Structural heart (TAVR, TEER) | 87 | 1,733+5.1%/yr | +5.1%/yr | 3.11.8× | 0% | 2,780 in 2030+8.2%/yr |
| Mechanical circulatory support | 1 | 304−3.4%/yr | −3.4%/yr | 0.71.1× | 0% | 490 in 2030+8.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| DBS & VNS | 3 | 324−2.1%/yr | −2.1%/yr | 0.72.2× | 0% | 460 in 2030+6.1%/yr |
| Aneurysm & intracranial embolization | 8 | 304+10%/yr | +10%/yr | 0.71.7× | 0% | 720 in 2030+16%/yr |
| Stroke thrombectomy | 6 | 178−8.1%/yr | −8.1%/yr | 0.41.0× | 0% | 280 in 2030+7.8%/yr |
| CSF shunts | 3 | 172+4.2%/yr | +4.2%/yr | 0.42.1× | 0% | 340 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 153 | 81,628+7.9%/yr | +7.9%/yr | 176.33.1× | 69% | 138,000 in 2030+9.1%/yr |
| Vitreoretinal surgery | 21 | 1,192−4.8%/yr | −4.8%/yr | 2.71.1× | 73% | 1,540 in 2030+4.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 399 | 47,636−3.7%/yr | −3.7%/yr | 109.91.0× | 35% | 59,400 in 2030+3.8%/yr |
| ERCP & endoscopic ultrasound | 37 | 2,446−5.1%/yr | −5.1%/yr | 5.51.4× | 3% | 3,110 in 2030+4.1%/yr |
| Bronchoscopy & lung nodule | 28 | 1,774+6.4%/yr | +6.4%/yr | 4.01.1× | 0% | 3,640 in 2030+13%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.